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 The HAD superfamily contains enzymes that catalyze carbon or phosphate transfer 
reactions.  One family within the HAD superfamily is the p-nitrophenyl phosphatase (PNPPase) 
family.  Members of this family are all phosphatases that cleave the substrate analog p-
nitrophenyl phosphate, in addition to their biologically significant substrate.  Interestingly, 
among the small number of family members that have been characterized, there is a wide variety 
of biologically relevant activities.  YZGD from Paenibacillus thiaminolyticus has pyridoxal 
phosphatase activity, catalyzed by a HAD superfamily domain, as well as a CDP-alcohol/sugar 
nucleotide hydrolase activity, catalyzed by a Nudix hydrolase domain.  Determining the structure 
of this enzyme would result in valuable information to contribute to our knowledge and 
understanding of the HAD superfamily and the Nudix hydrolase superfamily.  Sufficient 
quantities of sufficiently pure YZGD are necessary to perform x-ray crystal structure 
determination.  A histidine tag was added to the enzyme so that it can be purified by nickel 
affinity chromatography.  This was done by cloning the gene into pET19b, a plasmid containing 
a sequence encoding a string of ~10 histidines, and expressing the protein in Escherichia coli 
BLR(DE3).  The tagged YZGD expresses well, is soluble, and retains full activity.  It appears to 
be completely purified by nickel affinity chromatography.  This will now allow YZGD to be 











The HAD superfamily, named for haloacid dehalogenase (the first enzyme discovered for 
the superfamily), contains a remarkable variety of enzymes.  Members are found in all three 
domains of life, and include dehalogenases, sugar phosphomutases, phosphonatases, ATPases, 
and phosphoesterases.  There are 33 major enzyme families within the HAD superfamily, the 
majority of which are phosphoesterase families.  At least five of the HAD superfamily proteins 
exist in all three domains of life, indicating that they were present in the last universal common 
ancestor of all life on earth (Burroughs, et al. 2006).  HAD superfamily enzymes share a version 
of the Rossmanoid α/β fold, which has alternating β-α units that form a three-layered α/β  
“sandwich.”  One unique feature of the HAD superfamily fold is that it contains two sites in 
which additional domains, or “caps,” can be inserted.  These caps distinguish between different 
families within the HAD superfamily, and often provide important structural or functional 
residues.  Members of the superfamily can contain caps in both sites, a cap in only one site, or no 
caps at all.  (Figure 1). (Burroughs et al. 2006)   
 
Figure 1: The classic HAD motif, showing the Rossmanoid fold and  




The active site of the HAD superfamily members is surrounded by four loops.  All 
superfamily members use an aspartate residue, located on loop 1, to catalyze a carbon or 
phosphoryl group transfer.  The phosphotransferases within the superfamily all require a Mg
2+
 
cofactor, which is coordinated by two carboxylate residues from loop 4.  The phosphoryl group 
of the substrate interacts with either a serine or threonine on loop 2, and a lysine or arginine on 
loop 3. (Allen and Dunaway-Mariano 2004) 
Figure 2: The important active site residues of HAD superfamily  
phosphotransferases (Allen and Dunaway-Mariano 2004). 
 
One interesting family found within the HAD superfamily is the p-nitrophenyl 
phosphatase family (PNPPase) (Koonin & Tatusov 1994).  The first members identified were 
enzymes from two species of yeast, Saccharomyces cerevisiae and Schizosaccharomyces pombe 
(Attias & Bonnet 1972; Yang et al. 1991).  These two enzymes were found to hydrolyze p-
nitrophenyl phosphate, which is a substrate analog not found in biological systems, but thus far, 
no biologically relevant substrate has been found for these two enzymes.   A large number of 
putative proteins have a high level of sequence similarity to the known family members, but only 
a few of these proteins have been characterized.  Despite the small number of enzymes that have 
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been characterized, a variety of activities have been found within this family (Figure 2).  NAGD 
from Escherichia coli is a family member that hydrolyzes uridine 5’-monophosphate (UMP) 
(Tremblay et al. 2006; Tirrell, I.M., Nguyen, A.T., Mentz, R.J., Slivka, E.J. and O’Handley, S.F. 
unpublished data).  There are homologues of NAGD in other organisms as well, including 
Shigella, Salmonella, and Yersinia pestis (Figure 3).  There are characterized pyridoxal 
phosphatases (PLPases) in the family: YZGD PLPase from Paenibacillus thiaminolyticus, which 
also contains a Nudix hydrolase domain (Tirrell et al. 2006), and PLPases found in humans and 
mice (Jang et al. 2007). Phosphoglycolate phosphatases (PGPases) are also found in this family; 
the two that have been characterized are from Chlamydomonas reinhardtii (a green algae) 
(Mamedov et al. 2001) and Staphylococcus aureus (Hill, J.K., Thomson, J.G., Strassner, A.M., 
and O’Handley, S.F., in preparation).  The PGPase from S. aureus has been shown to be a 
virulence factor (Begun et al. 2005), indicating its significance in the cell. 
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S cerevisiae PNPPase   ----------------------MTAQQGVPIKITNKEIAQEFLDKYDTFLFDCDGVLWLG 38 
S pombe PNPPase        ----------------------------MAKKLSSPKEYKEFIDKFDVFLFDCDGVLWSG 32 
C reinhardtii PGPase   MLSLKQLPSARCAARPVRPVRRMVAAQASARPIATNEQKLELLKKVECFIFDCDGVIWLG 60 
S aureus PGPase        ------------------------------------------MKQYKAYLIDLDGTMYMG 18 
NAGD UMPase            -------------------------------------------MTIKNVICDIDGVLMHD 17 
YZGD PLPase            ----------------------------------------MLFDAFDVFLFDLDGVIYVG 20 
H sapiens PLPase       ---------------------------MARCERLRGAALRDVLGRAQGVLFDCDGVLWNG 33 
                                                                        . * ** .    
 
S cerevisiae PNPPase   SQALPYTLEILDLLKQLGKQLIFVTNNSTKSRLAYTKKFASFGID-VKEEQIFTSGYAPA 97 
S pombe PNPPase        SKPIPGVTDTMKLLRSLGKQIIFVSNNSTKSRETYMNKINEHGIA-AKLEEIYPSAYSSA 91 
C reinhardtii PGPase   DKVIEGVPETLDMLRGMGKKVFFVTNNSTKSRAGYMSKFQSLGLN-VKAEEIYSSSYAAA 119 
S aureus PGPase        TDEIDGAKQFIDYLNVKGIPHLYVTNNSTKTPEQVTEKLREMHID-AKPEEVVTSALATA 77 
NAGD UMPase            NVAVPGAAEFLHGIMDKGLPLVLLTNYPSQTGQDLANRFATAGVD-VPDSVFYTSAMATA 76 
YZGD PLPase            PEALPGAVEALERLRSGGKTIRFLTNNPCMTREQTAARLNRLGIE-AAKDEVISSGWATA 79 
H sapiens PLPase       ERAVPGAPELLERLARAGKAALFVSNNSRRARPELALRFARLGFGGLRAEQLFSSALCAA 93 
                          .      .  .   *     ..*    .      .                *    * 
 
S cerevisiae PNPPase   VYIRDFLKLQ-PGKDKVWVFGESGIGEELKLMGYESLGGADSRLDTPFDAAKSPFLVNGL 156 
S pombe PNPPase        TYVKKVLKL--PADKKVFVLGEAGIEDELDRVGVAHIGGTDPSLRR--ALASEDVEKIGP 147 
C reinhardtii PGPase   AYLESINFN-----KKVYVIGETGILEELDLKGIRHVGGPGD-ADKKVTLKSGEFMEH-- 171 
S aureus PGPase        DYISEQSPGAS-----VYMLGGSGLNTALTEAGLVIKN---------------------- 110 
NAGD UMPase            DFLRRQEGKK------AYVVGEGALIHELYKAGFTITD---------------------- 108 
YZGD PLPase            CCLRERRAGS------VYVLGDEHLERECRDAGLDIVD---------------------- 111 
H sapiens PLPase       RLLRQRLPGPPDAPGAVFVLGGEGLRAELRAAGLRLAG--------------DPSAGDGA 139 
                         .             ... *   .       *                            
 
S cerevisiae PNPPase   DKDVSCVIAGLDTKVNYHRLAVTLQYLQK-DSVHFVGTNVDS-TFPQKGYTFPGAGSMIE 214 
S pombe PNPPase        DPSVGAVLCGMDMHVTYLKYCMAFQYLQD-PNCAFLLTNQDS-TFPTNGKFLPGSGAISY 205 
C reinhardtii PGPase   DHDVGAVVVGFDRYVNYYKIQYATLCIRENPGCMFIATNRDAVTHLTDAQEWAGNGSMVG 231 
S aureus PGPase        DEHVDYVVIGLDEQVTYEKLAIATLGVRN--GATFISTNPDVSIPKERGF-LPGNGAITS 167 
NAGD UMPase            -VNPDFVIVGETRSYNWDMMHKAAYFVAN--GARFIATNPDT----HGRGFYPACGALCA 161 
YZGD PLPase            VNAAEAVVVGWSDDLTLRDIQSAVTRIAN--GAQFIATNADWSFPGPDGP-MMAVGTAVE 168 
H sapiens PLPase       APRVRAVLVGYDEHFSFAKLREACAHLRD-PECLLVATDRDPWHPLSDGSRTPGTGSLAA 198 
                             *. *     .          .        . *. *            . *.    
 
S cerevisiae PNPPase   SLAFSSNRRPSYCGKPNQNMLNSIISAFNLDRSKCCMVGDRLNTDMKFGVEGGLGGTLLV 274 
S pombe PNPPase        PLIFSTGRQPKILGKPYDEMMEAIIANVNFDRKKACFVGDRLNTDIQFAKNSNLGGSLLV 265 
C reinhardtii PGPase   AIVGSTKREPIVVGKPSDFMLKNISASLGLRPDQIAMVGDRLDTDIMFGKNGGLA-TALV 290 
S aureus PGPase        VVSVSTGVSPQFIGKPEPIIMVKALEILGLDKSEVAMVGDLYDTDIMSGINVGMD-TIHV 226 
NAGD UMPase            GIEKISGRKPFYVGKPSPWIIRAALNKMQAHSEETVIVGDNLRTDILAGFQAGLE-TILV 220 
YZGD PLPase            AIKMASGKTPYIVGKPYPYMFRQALQHV-EDWSRAVMFGDTPDADIAGAHRIGIS-AVLI 226 
H sapiens PLPase       AVETASGRQALVVGKPSPYMFECITENFSIDPARTLMVGDRLETDILFGHRCGMT-TVLT 257 
                        .   .       ***   .                  **    *.  .    .  .    
 
S cerevisiae PNPPase   LSGI---ETEERTLKISHDYPRPKFYIDKLGDIYALTNNEL--- 312 
S pombe PNPPase        LTGV---SKEEEILEKDAP-VVPDYYVESLAKLAETA------- 298 
C reinhardtii PGPase   LSGV---TTP-EVLNSPDNKVHPDFVLNSLPDLLSVKEKAMVAA 330 
S aureus PGPase        QTGV------STLEDVQNKNVPPTYSFKDLNEAIAELEK----- 259 
NAGD UMPase            LSGVS------SLDDIDSMPFRPSWIYPSVAEIDVI-------- 250 
YZGD PLPase            SSGP------YTGYSSARDYRKPDAIIPDL-------------- 250 
H sapiens PLPase       LTGVSRLEEAQAYLAAGQHDLVPHYYVESIADLTEGLED----- 296 
                        .*                   *      .            
 
Figure 2: Multiple sequence alignment of known enzymes of the P7PPase family.  Amino 
acids that are conserved are marked by characters below the sequences (‘*’ represents 
identical amino acids, and ‘.’ represents similar amino acids).  Residues conserved within 
all HAD superfamily members are highlighted in gray.  The enzyme names are indicated to 
the left.  YZGD has been truncated to show only its HAD superfamily domain (the first 250 
amino acids), omitting the domain containing the 7udix signature sequence for clarity. 
6 
 
E_coli          MTIKNVICDIDGVLMHDNVAVPGAAEFLHGIMDKGLPLVLLTNYPSQTGQDLANRFATAGVDV 
Shigella        MTIKNVICDIDGVLMHDNVAVPGAAEFLHGIMDKGLPLVLLTNYPSQTGQDLANRFATAGVDV 
Salmonella      MTIKNVICDIDGVLMHDNVAVPGAAEFLTGILEKGLPLVLLTNYPSQTGQDLANRFATAGVNV 
Y_pestis        MTIKSVICDIDGVLLHDNTAIKGANDFLARIQDAGMPLVILTNYPSQTAQDLTNRFITAGLDV 
Shewanella      --MKNIICDIDGVLLHDNKLIPGSDKFIHRVLDQGNPLVILTNYPVQTGKDLQNRLSAAGIDV 
                **.* .********.***  . *.  *.  . . * ***.***** **. ** **   **. * 
 
E_coli          PDSVFYTSAMATADFLRRQEGKKAYVVGEGALIHELYKAGFTITDVNPDFVIVGETRSYNWDM 
Shigella        PDSVFYTSAMATADFLRRQEGKKAYVVGEGALIHELYKAGFTITDVNPDFVIVGETRSYNWDM 
Salmonella      PDSVFYTSAMATADFLRRQEGKKAYVVGEGALIHELYKAGFTITDVNPDFVIVGETRSYNWDM 
Y_pestis        PESAFYTSAMATADFLRRQDGKKAYVIGEGALVHELYKAGFTITDINPDFVIVGETRSYNWDM 
Shewanella      PEECFYTSAMATADFLKHQEGSKAFVIGEGALTHELYKAGFTITDINPDFVIVGETRSYNWDM 
                *.  ************..*.* **.*.***** ************.***************** 
 
E_coli          MHKAAYFVANGARFIATNPDTHGRGFYPACGALCAGIEKISGRKPFYVGKPSPWIIRAALNK 
Shigella        MHKAAYFVANGARFIATNPDTHGRGFYPACGALCAGIEKISGRKPFYVGKPSPWIIRAALNK 
Salmonella      MHKAAFFVANGARFIATNPDTHGRGFYPACGALCAGIEKISGRKPFYVGKPSPWIIRAALNK 
Y_pestis        MHKAAYFVANGARFIATNPDSHGHGFAPACGALCAPIEKISGRKPFYVGKPSPWIIRAALNK 
Shewanella      IHKAAGFVARGARFIATNPDTHGPAYSPACGALCSPIERITGKKPFYVGKPSSWIIRSALNH 
                .**** *** **********.** .. *******. **.*.*.********* ****.***. 
 
E_coli          MQAHSEETVIVGDNLRTDILAGFQAGLETILVLSGVSSLDDIDSMPFRPSWIYPSVAEIDVI 
Shigella        MQAHSEETVIVGDNLRTDILAGFQAGLETILVLSGVSSLDDIDSMPFRPSWIYPSVAEIDVI 
Salmonella      MQAHSEETVIVGDNLRTDILAGFQAGLETILVLSGVSTINDIDSMPFRPSWIYPSVAEIDVI 
Y_pestis        MQAHSESTVIVGDNLRTDILAGFQAGLETILVLSGVSTLTDIDAMPFRPSYVYPSVADIDII 
Shewanella      INGHSENTVIIGDNMRTDILAGFQAGLETILVTSGVSKLEDIDKEPFRPNHVFACAGDIDVV 
                ...*** ***.***.***************** **** * ***  ****  .. ....**.. 
 
Figure 3: Alignment of homologues of 7AGD in pathogenic bacteria.  Identical amino acids 
are indicated by a ‘*’ and similar amino acids are indicated by a ‘.’. 
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YZGD is a particularly interesting member of the PNPPase family because, in addition to 
YZGD’s HAD domain responsible for its PLPase activity, it has a second domain containing the 
signature sequence of the Nudix hydrolase superfamily responsible for its activity on CDP-
alcohols, ADP-sugars, and to a limited extent GDP-sugars and UDP-sugars (Tirrell et al. 2006).  
The Nudix hydrolase superfamily contains diverse enzymes that hydrolyze nucleotide derivatives 
and are found in a variety of organisms (McLennan 2006).  Therefore, the crystal structure of 
YZGD would be interesting to those who study the various Nudix hydrolases, in addition to 
those interested in the HAD superfamily.   
In early 2006, the structure of the human PLPase family member was determined (PDB 
ID: 2CFT).  The structure of YZGD could be compared to this structure to seek out similarities 
in structure that lead to specific PLPase activity.  It would be the first structure of a prokaryotic 
PLPase in the HAD superfamily, as well as the first structure of an enzyme with dual 
phosphatase and Nudix hydrolase activity. 
The yzgd gene has previously been subcloned into a pET plasmid and used to transform 
E. coli HMS174(DE3).  The YZGD protein has been shown to have good expression levels and 
solubility.  Purification included sonication to break open the cells, streptomycin to remove the 
nucleic acids, ammonium sulfate fractionation, size exclusion chromatography, and anion 
exchange chromatography (Tirrell et al. 2006).   
The goal of this project was to work out conditions that would increase the amount and 
purity of YZGD to be used in x-ray crystallography, since a high yield of pure protein is 
necessary for x-ray crystal structure determination.  It was proposed to scale up the expression 
and purification to obtain milligram quantities of protein to work with.  Expression was 
originally carried out at 37°C, however the expression temperature was lowered to 15°C to 
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increase both expression and solubility; this technique has been successful for a number of other 
proteins in the lab.  Purification was modified, from using gravity chromatography to “FPLC” 
columns on the HPLC, for higher resolution in protein purification.  The success of each 
purification step was measured using SDS-PAGE to evaluate purity, Bradford assays to quantify 
protein, and enzyme assays to determine specific activity.  However, scaling up expression, 
lowering expression temperature, and modifying the chromatography procedures still did not 
yield pure enough YZGD, thus we created a His•tagged protein and carried out affinity 
chromatography purification.  Here we show that we have successfully created a subclone that 
expresses soluble His•tagged YZGD, and that we can purify it to an essentially pure state via 











Materials and Methods 
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YZGD expression and purification 
Cell culture and expression  
The YZGD protein was expressed in Escherichia coli HMS174(DE3) cells (Novagen) 
containing the pETYZGD plasmid.  The cells were grown in Luria-Bertani media with 100µg/ml 
ampicillin at 37°C until they reached an A600 of 0.6.  The cultures were induced to express the 
protein with 1mM isopropyl β-D-thiogalactoside.  Expression was conducted under two 
conditions, to determine which would produce the greatest yield of soluble protein.  In the first 
condition, the culture was incubated at 37°C, induced, then incubated for 3 more hours at 37°C, 
after which the cells were harvested.  Alternatively, the culture was cooled from 37°C to 15°C, 
induced, and incubated for 24 hours at 15°C before harvesting. 
 
Cell harvesting and sonication 
 Cells were harvested by centrifugation, washed with buffered saline, centrifuged again 
and stored at -80°C.  Prior to sonication, cells were thawed and resuspended in two volumes of 
TED buffer (50mM Tris-HCl (pH 7.5), 1mM EDTA, 0.1mM DTT).  Cells were broken open by 
sonication using a Branson sonifier, and the resulting solution was centrifuged to remove the 
insoluble proteins and cell debris from the soluble protein in the supernatant.   
 
Streptomycin fractionation 
 Streptomycin sulfate was added to the sonicated supernatant to a concentration of 1% 
(w/v) and incubated, with stirring, for 15 minutes on ice.  This was centrifuged to remove the 




Ammonium sulfate fractionation and concentration 
 Saturated ammonium sulfate was added to the resulting supernatant to a concentration of 
55%, and incubated on ice for 15 minutes.  The precipitate, containing YZGD, was obtained by 
centrifugation and resuspended in TED buffer.      
 
Size exclusion chromatography 
 Size exclusion chromatography was conducted at room temperature, using the GE 
Healthcare HiPrep™ Sephacryl™ S-200 16/60 column, which has a volume of 120 ml of resin.  
All solvents were filtered, degassed, and sparged with helium to eliminate dissolved oxygen.  
The column buffer used contained 50mM Tris-HCl pH 7.5, 0.1mM DTT, 1mM EDTA, and 0.2M 
NaCl.   
The column was equilibrated with 2 column volumes of column buffer.  The protein 
sample (concentrated to less than 2ml) was loaded onto the column and the mobile phase was run 
at 0.5 ml/min.  Fractions of 1ml were collected and monitored at 280nm and 290nm. 
 
Dialysis 
 Prior to ion exchange chromatography, the protein sample was dialyzed to lower the salt 
concentration.  Dialysis was performed with Pierce Slide-A-Lyzer dialysis cassettes with a 10kD 
molecular weight cutoff (MWCO) membrane.   The dialysis buffer contained 50mM tris-HCl 
(pH 7.5) and 1mM EDTA.  The sample was dialyzed for 6 hours, transferred to fresh buffer, then 






Ion exchange chromatography 
 FPLC Method 
Buffer A contained Tris-HCl (pH 7.5) and 1mM EDTA.  Buffer B contained Tris-
HCl (pH 7.5), 1mM EDTA, and 1M NaCl.  Buffers were filtered, degassed, and sparged 
with helium. 
The GE Healthcare HiTrap™ Sepharose™ DEAE (Diethylaminoethyl) FF 1ml 
column was used.  The column was washed with 5ml each of water, Buffer A, Buffer B, 
then Buffer A, at 1ml/min flow rate.  The sample was loaded onto the column, and 1ml 
fractions were collected.  The column was washed with 5ml of Buffer A. 
YZGD was eluted with either a 20ml gradient from 0M NaCl (Buffer A) to 0.5M 
NaCl in Buffer A, or a stepwise elution was carried out where 5ml each of the following 
salt concentrations were run consecutively over the column: 0M, 0.1M, 0.2M, 0.3M, 
0.4M, 0.5M NaCl.   
 Gravity Method 
Buffer A contained 50mM Tris-HCl (pH 7.5) and 1mM EDTA.  Additional 
buffers were made with the following NaCl concentrations: 0.1M, 0.2M, 0.25M, 0.3M, 
0.4M, and 0.5M, in addition to 50mM Tris-HCl (pH 7.5) and 1mM EDTA. 
A 5ml DEAE Sepharose column was equilibrated with ~120ml of buffer A. 
Dialyzed protein sample (4.5ml) was applied to the column, and fraction collection 
began, collecting ~2ml fractions.  Sequentially, 8ml of each buffer was applied over the 





 The Bradford protein assay (Bradford 1976) was used to determine protein concentration 
throughout the purification process.  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) using a stacked gel (Laemmli 1970) was used to examine the purity and quantity 
of YZGD.   
Enzymatic activity assays were conducted to determine the levels of active YZGD 
protein.  A standard reaction mixture contained 50mM Tris-Maleate (pH 5.0), 5mM MgCl2, 
1mM dithiothreitol, and 4mM pyridoxal phosphate (PLP).  Between 0.5 and 4.0 units of YZGD 
were added to 50µl of the reaction mix.  Reactions were incubated at 37°C for 30 minutes, and 
quenched by the addition of 50µl of 4 parts 20% packed Norit to 1 part 7% perchloric acid.  
After centrifugation, 50µl of the supernatant was analyzed for phosphate using the method of 
Ames and Dubin. 
 
YZGD His•tag Subcloning, Expression and Purification 
Plasmid Purification 
 The pETYZGD and pET19b (HisTag) plasmids were purified from overnight cultures of 
E. coli BLR(DE3) as described in Sambrook and Russell.  The cells were disrupted by alkaline 
lysis using a NaOH/SDS solution, the chromosomal DNA was precipitated, and the cell extract 
was treated with RNase A and incubated at 37°C to degrade RNA.  Phenol:chloroform was used 
to further purify the cell extract, and the plasmid DNA was precipitated with ethanol at -80°C.  
The sample was centrifuged, the ethanol discarded, and the DNA pellet was dried and 
resuspended in water.  The DNA was further purified by a polyethylene glycol (PEG)-NaCl 
precipitation overnight on ice, using a 6.5% PEG and 0.8M NaCl solution to remove the tRNA.  
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DNA concentration was determined by measuring the absorbance at 260nm, and both 
concentration and purity were verified by gel electrophoresis. 
 
Restriction Enzyme Digests 
 The yzgd gene was excised from the pETYZGD plasmid by digesting with NdeI and BlpI 
restriction enzymes (New England Biolabs).  The pET19b plasmid was also digested with NdeI 
and BlpI to create matching “sticky” ends.  After verification by gel electrophoresis that the 
digests were complete, the excised gene and the plasmid were gel-purified.   This involved 
running each sample on a 0.7% agarose gel, staining with ethidium bromide, and physically 
cutting the appropriate band out of the gel.  The DNA was extracted from the gel using the Gene-
clean® kit (MPBiomedicals).  The concentration of DNA was estimated using gel 
electrophoresis and DNA standards. 
 
Ligation 
 The yzgd gene was ligated into the pET19b plasmid using T4 DNA ligase (Invitrogen).  
Several ratios of plasmid:gene were used.  The ligations were conducted at 15°C for 24 hours. 
 
Transformation 
 E. coli DH5α competent cells (Invitrogen) were transformed with each of the ligation 
mixtures.  Transformed cells were grown on LB plates containing 100 μg/ml ampicillin to select 
for cells containing the pET19YZGD plasmid (and therefore the ampicillin resistance gene). 
 Plasmids were purified according to the procedure in Sambrook and Russell, to determine 
whether they were successful recombinants.  Overnight cultures were grown from colonies and 
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plasmids were purified from the cultures.  The isolated plasmids were examined using gel 
electrophoresis to determine which colonies contained the recombinant plasmids 
(pET19YZGD(HisTag)).   
 
Verification 
As an additional verification step, the purified plasmids were digested using BamHI 
(New England Biolabs) and again run on a gel.  There is a BamHI site in pET19YZGD but not in 
pET19b digested with NdeI and BlpI, so the recombinant plasmid will appear as primarily linear 
DNA on the gel, while the pET19b plasmid will still be a supercoiled plasmid or a smaller linear 
band if not digested fully prior to ligation. 
Once successfully transformed cells were identified, several were used to create freezer 
stocks for future use.  One freezer stock was used to create an overnight culture for a plasmid 
purification, and this plasmid DNA was used to transform BLR(DE3) competent cells (Novagen) 
to be used for expression.  Freezer stocks were made of the expression cell line as well. 
 
Expression 
 A 100ml culture of pET19YZGD(HT) in E. coli BLR(DE3) cells was prepared for 
expression.  As a control, a culture of pETYZGD in HMS174(DE3) was grown under identical 
conditions.  Expression, harvesting, and sonication were performed simultaneously in the two 
cultures, in the same manner as the experiments described earlier.  After sonication, the cell 
extracts were tested for protein concentration and enzymatic activity.  The samples were dialyzed 




Affinity Chromatography Purification 
Nickel Affinity resin from Novagen was used to make two 1ml columns for affinity 
purification, one for the His•tagged protein and one for the untagged control.  Each column was 
equilibrated with Binding Buffer, containing 20mM Tris-HCl (pH 8.0), 5M NaCl, and 5mM 
imidazole.  After column equilibration, the protein sample was loaded and fractions were 
collected.  The column was washed with 5ml Wash Buffer to elute all other proteins, which 
contained a higher imidazole concentration than Binding Buffer (60mM imidazole) but was 
otherwise the same.  Next, 5ml Elution Buffer (250mM imidazole) was used to elute the bound 
His•tagged YZGD protein. 
To determine the contents of each fraction, the protein concentration and enzymatic 
activity were measured, and fractions containing protein were run on a SDS polyacrylamide gel 
to examine each fraction and the purity of the eluted His•tagged YZGD protein. 
 
 定䜸 ▃ ▅▅ƺ″               Results and Discussion 
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YZGD expression and purification 
 
The YZGD enzyme was first expressed and purified using the same methods as described 
in Tirrell et al. (2006).  Table 1 and the protein gel in Figure 5 show the results of this initial 
purification.  This protein came from a 2L batch of E. coli HMS(174) cells incubated at 37°C 
during expression of YZGD.  The dark, wide band in lane 2 shows that the protein overexpressed 
successfully.  However, throughout the purification steps, there were many other contaminating 
proteins remaining.  This lead to the decision to express the protein at 15°C, with hope that it 
would express better and be more soluble.  This has been the case with a number of other 




















Figure 5: Purification of YZGD protein expressed at 37°C.  Lane 1: molecular 
weight markers, Lane 2: crude extract, Lane 3: sonicated supernatant, Lane 4: 
streptomycin fractionation supernatant, Lane 5: 55% ammonium sulfate fraction, 
Lane 6: size exclusion pooled fractions, Lane 7: ion exchange pooled fractions.  
Some contaminating proteins were eliminated during each step of purification, but 






















Sonication 11.9 9.57 114 8.69 1.10 103 
Ammonium 
sulfate 55% 
1.28 56.7 72.3 23.9 2.37 30.5 
Size Exclusion 
Chromatography 
10.7 0.952 10.2 1.31 0.727 14.0 
Ion Exchange 
Chromatography 
7.00   1.50  10.5 
 
 
 When expressed at 15°C versus 37°C, the expression level of YZGD was comparable, or 
slightly better at 15°C as seen in Figure 6 (compare lane 3 to lane 7).  As a negative control, 
samples of cells containing only the expression vector pET11b (and therefore not expressing 













While expressing at a lower temperature did not significantly increase expression, the change in 
expression temperature from 37°C to 15°C led to a significant increase in solubility.  After 
sonicating the cells to break them open and centrifugation to remove insoluble proteins and other 
cellular debris, most of the YZGD protein was present in the supernatant.   
 
 
Table 1: Purification of YZGD protein expressed at 37°C. 
Figure 6: Comp rison of expr ssion of YZGD protei  from pETYZGD in E. coli 
HMS174(DE3), 15°C vs 37°C.  Lane 1: molecular weight markers, Lane 2: 37°C  
pETYZGD prior to induction, Lane 3: 37°C pETYZGD at 3 hours after induction, Lane 
4: 37°C pET11b prior to induction, Lane 5: 37°C pET11b at 3 hours after induction, 
Lane 6: 15°C pETYZGD prior to inductio , Lane 7: 15°C pETYZGD at 24 hours after 
induction, Lane 8: 15°C pET11b prior to induction, Lane 9: 15°C pET11b at 24 hours 




While expressing at a lower temperature did not significantly increase expression, the 
change in expression temperature from 37°C to 15°C led to a significant increase in solubility.  
After sonicating the cells to break them open and centrifugation to remove insoluble proteins and 




Figure 7: Comparison of solubility of YZGD protein, expressed at 15°C vs 37°C.  Lane 
1: 15°C crude extract, Lane 2: 15°C freeze thaw supernatant, Lane 3: 15°C freeze thaw 
pellet, Lane 4: 15°C sonicated supernatant, Lane 5: 15°C sonicated pellet, Lane 6: 37°C 
crude extract, Lane 7: 37°C sonicated supernatant, Lane 8: 37°C sonicated pellet, Lane 
9: 15°C pET11b control sonicated supernatant, Lane 10: molecular weight markers.  
YZGD expressed at 15°C is mostly in the sonicated supernatant, indicating greater 
solubility compared to the protein expressed at 37°C. 
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Purification of the protein expressed at 15°C included the steps shown in Figure 8.  
YZGD did not elute from the cells in a freeze-thaw step, and thus the pellet from this step was 
processed, as it contained YZGD.  A portion of YZGD was found to be soluble upon sonication, 
and the sonicated supernatant was processed further.  Streptomycin removed nucleic acid (DNA) 
from the sample.  Two rounds of anion exchange chromatography using a DEAE FPLC column 
from GE Healthcare removed some contaminating proteins from YZGD, but not enough to 
render YZGD pure.  A gravity DEAE anion exchange column further purified YZGD, but still 
not enough for the enzyme to be pure enough to crystallize for x-ray crystal structure 
determination.  Thus we decided to tackle the problem from a new perspective, to create a 



















Figure 8: Purification of YZGD protein expressed at 15°C.  Lane 1: crude extract, 
Lane 2: freeze-thaw pellet, Lane 3: sonicated supernatant, Lane 4: streptomycin 
supernatant, Lane 5: FPLC ion exchange fraction, Lane 6: 55% ammonium sulfate 
fraction, Lane 7: FPLC ion exchange fraction, Lane 8: dialyzed fraction, Lane 9: 
gravity ion exchange fraction, Lane 10: molecular weight markers.  The final protein 






























Sonication 2.45 31.2 76.4 17.8 1.75 43.6 
Streptomycin fraction 4.00   6.70  26.8 
Ion Exchange 
Chromatography 




2.40   2.98  7.15 
Ion Exchange 
Chromatography 
4.50      
Gravity Ion Exchange 
Chromatography 
   0.350   
 
*
 Detailed activity information was not determined for many steps of this procedure, 
because the purity of YZGD was not good enough to support using this procedure to 
prepare samples for crystallography. 
 
 
YZGD His•tag subcloning and purification 
 
 Since the purification of YZGD proved ineffective, it was decided that a His•tag would 
be added to the protein.  This sequence of histidines, attached to one end of the protein, would 
allow it to bind to Ni
2+
 ions.  Therefore, the cell extract could be run over a nickel affinity 
column, and when the bound protein is eluted, it should be pure YZGD.  The pET19b His•tag 
expression vector was used.  The map of this vector is shown in Figure 9, with the chosen 
restriction enzyme target sites marked by red rectangles.  Computational analysis showed that the 
yzgd gene did not contain either of these sites, so the same restriction enzymes could be used 
both to excise yzgd out of pETYZGD and to digest the pET19b plasmid, giving them “sticky” 
ends that can be ligated together easily. 
 





Figure 9: pET19b plasmid map.  Red rectangles indicate the digestion sites for 






The pET19b and pETYZGD plasmids were each purified from E. coli DH5α cells.  The 
amount of plasmid DNA obtained was calculated from the absorbance of the solution at 260nm, 
using the following equation:  




) · dilution factor  
where the dilution factor was 100.  The total DNA was calculated by multiplying the 
concentration by 120 µl since that is the volume of plasmid obtained.  The concentration and 
purity were verified qualitatively by gel electrophoresis (Fig. 10).  The intensity of the band of 











pET19b 0.047 235 28.2 











Table 3: Quantification of isolated pET19b and pETYZGD. 
Figure 10: Agarose gel electrophoresis of purified pET19b and pETYZGD.   
a) pET19b purification.  Lane 1: λ HindIII molecular weight  markers, Lane 2: 100ng 
pET19b, Lane 3: 100ng pET11b control.   
b) pETYZGD purification.  Lane 1: λ HindIII molecular weight  markers, Lane 2: 





Digestion and purification 
 
The pET19b plasmid was digested with BlpI and NdeI restriction enzymes.  
Simultaneously, single digests were prepared with each of the enzymes.  After 1 hour of 
digestion, these single digests were run on a 0.7% agarose gel alongside the undigested plasmid, 
for comparison (Fig. 11a).  Since the BlpI sample still contained some undigested plasmid, the 
digestion was allowed to proceed.  After 2.5 hours (Fig. 11b), both samples appeared to be 












Figure 11: Digestion of pET19b by BlpI and AdeI. 
a) Results after 1 hour.  b) Results after 2.5 hours.  Lane 1: λ HindIII molecular weight 
markers, Lane 2: undigested pET19b, Lane 3: pET19b digested by AdeI, Lane 4: 
pET19b digested by BlpI.  While the BlpI digestion was not complete at 1 hour, both 




The same procedure was conducted with the pETYZGD plasmid, to excise the yzgd gene 
from the plasmid.  After 1 hour, the two single digests of pETYZGD were analyzed by gel 
electrophoresis (Fig. 12).  The majority of the DNA was linear, digested plasmid, but there was 
still a small fraction of remaining undigested plasmid.  The digestions were allowed to proceed 


















Figure 12: Digestion of pETYZGD by BlpI and AdeI, after 1 hour.  Lane 1: λ HindIII 
molecular weight markers, Lane 2: pETYZGD digested by AdeI, Lane 3: pETYZGD 
digested by BlpI, Lane 4: undigested pETYZGD.  There was still a small amount of 
undigested plasmid after 1 hour which was completely digested after 2.5 hours. 
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 The digested pET19b plasmid was run in one large lane on a gel to be cut out for 
purification, as shown in Figure 13.  Only one band is visible because the fragment excised 
between the two restriction sites is so small (~60 bases) that it would have quickly run off of this 
gel.  Unfortunately, this means that any plasmids that were only digested once will be similar in 
size to the plasmids that were completely digested, and will not be separated in the gel, hence the 
importance of the single digest controls shown above.  The band is consistent with the 5.7kb size 









Figure 13: Gel purification of digested pET19b plasmid DAA.  Lane 1: λ HindIII 
molecular weight markers, Lane 2: 1µl of digested pET19b, Lane 3: rest of digested 
pET19b.  The band was cut from the gel for purification. 
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 Digested pETYZGD was also run on a gel for purification (Fig. 14).  The bottom band is 
the yzgd gene, to be cut out of the gel for purification.  This is consistent with the known size of 
the yzgd gene, approximately 1.2kb  The YZGD gene is well separated from the plasmid DNA 
for ease in purification. 
 
 
Figure 14: Gel purification of yzgd gene from digested pETYZGD plasmid DAA.  Lane 
1: λ HindIII molecular weight markers, Lane 2: 1µl of digested pETYZGD, Lane 3: rest 





 The concentration of purified plasmid was determined by gel electrophoresis.  Two 
different volumes of plasmid, 1µl and 2µl, were run alongside 100ng of pET11b plasmid.  The 
bands were visually compared to the control to estimate the concentration.  For pET19b, shown 
in Figure 15, the 2µl band was comparable to the 100ng control.  Therefore, the concentration 















Figure 15: Quantitation of purified digested pET19b plasmid.  Lane 1: λ HindIII 
molecular weight markers, Lane 2: 1µl  pET19b, Lane 3: 2µl pET19b, Lane 4: 100ng 
pET11b for comparison.  By comparison to the band of known concentration, the 
pET19b solution appears to be about 50ng/µl. 
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 The same procedure was followed to quantitate the yzgd DNA (Fig. 16).  In this case, the 
2µl band was about half the intensity of the 100ng control band.  Therefore, there were 






Figure 16: Quantitation of purified excised yzgd gene.  Lane 1: λ HindIII molecular 
weight markers, Lane 2: 1µl  yzgd, Lane 3: 2µl yzgd, Lane 4: 100ng pET11b for 
comparison.  By comparison to the band of known concentration, the yzgd solution 
appears to be about 25ng/µl. 
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Ligation and Transformation  
 
 As shown in Table 4, varying amounts of the purified yzgd were added to the digested 
pET19b plasmid, and ligated together to form a new recombinant plasmid.  The resulting 
plasmids were transformed into E. coli DH5α cells and grown on selective LB plates containing 
100 μg/ml ampicillin.  The number of colonies that grew is also shown in Table 4.  The colonies 
resulting from ligation E, the negative control to which no yzgd gene was added, indicate that 
some pET19b plasmids were not completely doubly digested, and re-ligated to themselves.  
However, the other ligations yielded 4-10 times more colonies, an initial indication that the 










A 200 6.25 2.4 13 
B 200 12.5 1.2 16 
C 200 25 0.6 37 
D 200 50 0.3 15 
E 200 0 --- 4 
pUC control --- --- --- ~160 
 
 
Table 4: Ligations of pET19b with yzgd, and results of transformation into E. coli DH5α 




 Twelve colonies were chosen from ligations A-D, grown as overnight cultures in LB 
media, and plasmids were isolated from these cultures.  The isolated plasmids were analyzed by 
gel electrophoresis to determine if they were the new recombinant pET19bYZGD plasmid.  This 
is shown in Figure 17.  Plasmid DNA from colonies A2 and B2 was consistent in size with the 
pET19b plasmid, which reinforces the earlier assumption that some fraction of the pET19b 
plasmids were only digested by one of the two restriction enzymes and were ligated back 
together.  Colony A1 contains a smaller unknown DNA.  All other colonies appeared to be of the 






Figure 17: Purified plasmids from transformations of E. coli DH5α with pET19b-YZGD 
ligation mixtures.  Lane 1: λ HindIII molecular weight markers, Lane 2: pET19b 
control, Lanes 3-14: purified plasmid from colonies A1, A2, B1, B2, C1, C2, C3, C4, C5, 
C6, D1, D2.  Colonies B1, C1, C2, C3, C4, C5, C6, D1, D2 contain plasmids larger than 




To verify the success of subcloning, the isolated plasmids were digested with BamHI.  
The pET19b plasmid contains a single BamHI site, which is cut out when cloning the yzgd gene 
into the plasmid.  Since the yzgd gene itself contains a BamHI restriction site, the 
pET19YZGD(HT) plasmid should be digested by BamHI to produce a linear plasmid.  Figure 18 
confirms the results shown in Figure 17.  A1 contains a plasmid too small to be 
pET19YZGD(HT).  A2 and B2 contain undigested pET19b (a small amount is relaxed or 
digested plasmid (upper band) but a majority is supercoiled plasmid (lower band)).  The rest of 
the colonies appear to contain pET19YZGD(HT) which can be digested by BamHI.  The 
overnight culture made from colony C6 was streaked to single colonies, and a single colony from 
this plate was cultured and used to make a freezer stock.   
Figure 18: Purified plasmids from transformations of E. coli DH5α with pET19b-YZGD 
ligation mixtures, digested with BamH1.  Lane 1: λ HindIII molecular weight markers, 
Lane 2: pET19b control, Lanes 3-14: digested plasmids from colonies A1, A2, B1, B2, 
C1, C2, C3, C4, C5, C6, D1, D2.  Colonies B1, C1, C2, C3, C4, C5, C6, D1, D2 appear to 






The recombinant pET19YZGD(HT) plasmid was isolated from the transformed E. coli.  
As with the plasmid purifications described earlier, the concentration of isolated DNA was 



















Table 5: Amount of isolated pET19YZGD(HT) DAA. 
Figure 19: Purified pET19YZGD(HT) plasmid.  Lane 1: λ HindIII molecular weight 
markers, Lane 2: 100ng pET19YZGD, Lane 3: 100ng pET19b, Lane 3: 100ng pET11b 






 The isolated pET19YZGD(HT) was used to transform E. coli cells for expression, and 
freezer stocks were made.  The new tagged protein and the original untagged protein (as a 
control) were overexpressed simultaneously.  Figure 20 shows the results of this expression.  The 
expression level of the His•tagged protein was comparable to that of the untagged protein, 
possibly higher.  An increase in expression level could be because different strains of E. coli 
were used to express the protein.  The BLR(DE3) cells used to express the tagged protein may be 




Figure 20: Comparison of expression: YZGD protein from pETYZGD plasmid in E. coli 
HMS174(DE3) vs YZGD(HT) protein from pET19YZGD(HisTag) plasmid in E. coli.  
Lane 1: molecular weight markers, Lane 2: expression of pET19YZGD(HT) prior to 
induction, Lane 3: expression of pET19YZGD(HT) at 24 hours after induction, Lane 4: 
expression of pETYZGD prior to induction, Lane 5: expression of pETYZGD at 24 
hours after induction.  The His•tagged YZGD expressed just as well as the untagged 





The solubility of the tagged and untagged YZGD was ascertained by analyzing the 
protein composition of the sonicated supernatants and pellets by SDS-PAGE (Figure 21).  The 
solubility level of the His•tagged YZGD protein was satisfactory, with ~50% of the tagged 















Figure 21: Comparison of solubility: YZGD protein from pETYZGD plasmid in E. coli 
HMS174(DE3) vs YZGD(HT) protein from pET19YZGD(HT) plasmid in E. coli.  Lane 
1: molecular weight markers, Lane 2: pETYZGD freeze thaw pellet, Lane 3: pETYZGD 
freeze thaw supernatant, Lane 4: pETYZGD sonicated supernatant, Lane 5: pETYZGD 
sonicated pellet, Lane 6: pET19YZGD(HT) freeze thaw pellet, Lane 7: 
pET19YZGD(HT) freeze thaw supernatant, Lane 8: pET19YZGD(HT) sonicated 
supernatant, Lane 9: pET19YZGD(HT) sonicated pellet.  Both the untagged and tagged 
protein show good solubility, with a significant portion of the YZGD protein located in 
the supernatant after sonication.  
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The protein concentration of the sonicated supernatant of each culture was measured, and 
is recorded in Table 6.  The total protein in pET19YZGD(HT) in BLR(DE3) was nearly double 
that of the total protein in pETYZGD in HMS174(DE3).  This could be due to the use of 
different E. coli strains or to better expression or solubility of YZGD. 
 Likewise, the enzymatic activity was analyzed for each culture.  The pET19ZGD(HT) in 
BLR(DE3) culture had more than double the activity as compared to pETYZGD in 
HMS174(DE3), measured in units per mg of total protein.  Each unit is one nanomole of 
substrate cleaved per minute.  The increase in activity is most likely due to the increased 





















YZGD 1.06 8.26 8.76 6.5 1.27 6.9 

























 A pilot affinity chromatography purification experiment was performed to verify that this 
method would effectively purify the His•tagged protein.  Simultaneous experiments were 
performed using the tagged and untagged protein, and the results are shown in Figure 22.  When 
extract containing untagged YZGD was loaded onto the nickel column, proteins washed through 
the column.  The band of overexpressed YZGD is clearly visible in these fractions.  When the 
elution buffer was used, no other proteins were eluted from the columnm indicating that no 
proteins had bound to the nickel-containing resin.  In the case of the His•tagged YZGD (lanes 1-
5), many proteins eluted in the wash fractions, but little, if any, YZGD(HT) eluted in this stage.  
When elution buffer was applied, YZGD(HT) was eluted from the column, and appears to be 
pure as seen in lanes 4 and 5 of Figure 22. 
 
Figure 22: Ai-ATA affinity chromatography of tagged and untagged proteins.  Lane 1: 
YZGD(HT) wash fraction 1, Lane 2: YZGD(HT) wash fraction 2, Lane 3: YZGD(HT) 
wash fraction 3, Lane 4: YZGD(HT) elution fraction 1, Lane 5: YZGD(HT) elution 
fraction 2, Lane 6: YZGD wash fraction 1, Lane 7: YZGD wash fraction 2, Lane 8: 
YZGD wash fraction 3, Lane 9: YZGD elution fraction 1, Lane 10: YZGD elution 
fraction 2.  The untagged YZGD protein washes through the column immediately, while 














 The first purification methods for YZGD, involving size exclusion and ion exchange 
chromatography, were insufficient for obtaining protein pure enough for x-ray crystallography.  
While these methods had previously been used to purify the enzyme for determination of its 
substrate and quantitation of activity, the methods did not yield enough pure protein for 
crystallography.  Adding a histidine tag to YZGD before evaluating its activity would have been 
unwise, since this modification might have altered the enzyme’s activity in some way that we 
would have been unaware of.  However, since the activity of YZGD has now been thoroughly 
evaluated (Tirrell et al. 2006), any change in activity could be detected.   
The tagged YZGD(HT) protein has been shown to have good expression and solubility.  
It also appears to purify very effectively over a nickel affinity chromatography column, and 
retains its enzymatic activity throughout all of these steps, with a final specific activity 
comparable to the purified untagged YZGD.  Since this work, Julian Ramos has scaled up 
expression and purification to obtain a larger amount of the YZGD protein.  He also obtained 
excellent purification and activity.  The next step in the project is the crystallization of the 
protein with the help of our collaborator, Dr. Joseph Wedekind from the University of Rochester.  
It is possible that the tag will need to be removed from the protein before it will successfully 
crystallize into its native structure.  The crystallization process will be considerably easier now 
that there is a simple and effective way to purify large amounts of YZGD protein. 
The eventual determination of the three-dimensional structure of YZGD will be 
important to scientists who study HAD superfamily enzymes, as well as those who study Nudix 
hydrolase enzymes.  The structure of YZGD can be compared to known PLPase structures 
within the nitrophenyl phosphatase (PNPPase) family of the HAD superfamily, PNPPase family 
members with other substrates, HAD superfamily members not in the PNPPase family, and 
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Nudix hydrolases.  As more enzymes are characterized, in terms of both activity and structure, it 
becomes easier to identify features that determine substrate specificity.  For these reasons, the 
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